1. Home
  2. STE vs MEDP Comparison

STE vs MEDP Comparison

Compare STE & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo STERIS plc (Ireland)

STE

STERIS plc (Ireland)

SELL

Current Price

$218.12

Market Cap

21.3B

Sector

Health Care

ML Signal

SELL

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

SELL

Current Price

$620.11

Market Cap

17.2B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
STE
MEDP
Founded
1985
1992
Country
United States
United States
Employees
3700
N/A
Industry
Industrial Specialties
Biotechnology: Commercial Physical & Biological Resarch
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.3B
17.2B
IPO Year
2018
2016

Fundamental Metrics

Financial Performance
Metric
STE
MEDP
Price
$218.12
$620.11
Analyst Decision
Buy
Hold
Analyst Count
9
14
Target Price
$263.13
★ $595.92
AVG Volume (30 Days)
★ 611.6K
230.3K
Earning Date
11-04-2026
10-21-2026
Dividend Yield
★ 1.29%
N/A
EPS Growth
★ 27.90
20.98
EPS
7.93
★ 8.53
Revenue
★ $5,935,900,000.00
N/A
Revenue This Year
$7.35
$12.72
Revenue Next Year
$6.36
$6.33
P/E Ratio
★ $27.07
$71.77
Revenue Growth
★ 8.73
N/A
52 Week Low
$195.14
$373.00
52 Week High
$269.44
$677.90

Technical Indicators

Market Signals
Indicator
STE
MEDP
Relative Strength Index (RSI) 59.21 56.15
Support Level $216.22 $565.78
Resistance Level $220.39 $632.08
Average True Range (ATR) 3.86 18.61
MACD 1.56 -1.09
Stochastic Oscillator 87.21 58.18

Price Performance

Historical Comparison
STE
MEDP

About STE STERIS plc (Ireland)

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: